Compare JD.Com Inc (JD) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JD.Com Inc vs Mesoblast Limited — how do they compare? JD.Com Inc trades at $31.45 (market cap $44.04B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: JD.Com Inc is far larger — about 19.9× Mesoblast Limited's market cap, and JD.Com Inc pays a 3.13% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| JD | MESO | |
|---|---|---|
Market Cap | $44.04B | $2.21B |
Sector | Consumer Cyclical | Technology |
52-Week High | $36.17 | $20.96 |
52-Week Low | $25.19 | $12.88 |
Enterprise Value | $30.10B | $2.21B |
Dividend Yield | 3.13% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
